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Abstract: Six pimarane-type diterpenes isolated from Viguiera arenaria Baker and two 
semi-synthetic derivatives were evaluated in vitro against a panel of representative 
microorganisms responsible for dental root canal infections. The microdilution method was 
used for the determination of the minimum inhibitory concentration (MIC) and minimum 
bactericidal concentration (MBC) against Porphyromonas gingivalis, Prevotella 
nigrescens, Prevotella intermedia, Prevotella buccae, Fusobacterium nucleatum, 
Bacteroides fragilis, Actinomyces naeslundii, Actinomyces viscosus, Peptostreptococcus 
micros, Enterococcus faecalis and Aggregatibacter actinomycetemcomitans. The 
compounds ent-pimara-8(14),15-dien-19-oic acid, its sodium salt and ent-8(14),15-
pimaradien-3β-ol were the most active, displaying MIC values ranging from 1 to  
10 μg mL-1. The results also allow us to conclude that minor structural differences among 
these diterpenes significantly influence their antimicrobial activity, bringing new 
perspectives to the discovery of new chemicals for use as a complement to instrumental 
endodontic procedures. 
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1. Introduction  
Bacterial infections are the major cause of pulp and periradicular pathologies [1,2]. The genera 
Peptostreptococcus, Prevotella, Porphyromonas, Fusobacterium, Bacterioides, and Actinomyces are 
the most frequently identified as responsible for these pathologies [1,3]. During root canal treatment, 
mechanical instrumentation is a very important way to eliminate microorganisms [2,4]. However, this 
procedure alone does not result in a bacteria-free root canal system [2,4,5]. To promote bacteria 
eradication, the use of chemical agents has been employed [1,2,4,5]. Nevertheless, the different 
susceptibilities demonstrated by the oral pathogens, as well as the toxicity and allergenicity displayed 
by these chemicals, have made treatment very difficult [2-6]. This scenario illustrates the need to 
discover new chemicals to be used as complement to instrumental procedures. 
The wide variety of chemical structures encountered in plants provides new and important leads 
against pharmacological targets [7,8]. Some studies have demonstrated the great importance of 
botanical sources, as well as their isolated compounds, for application in dentistry [3,9-12]. Recently, 
our research group has concentrated efforts on the discovery of new compounds from plants that 
display antibacterial activity against oral pathogens. We have demonstrated that some pimarane-type 
diterpenes isolated from a Brazilian species of Viguiera are able to inhibit the growth of various 
cariogenic bacteria, such as Streptococcus salivarius, S. sobrinus, S. mutans, S. mitis, S. sanguinis, and 
Lactobacillus casei, with very promising MIC values ranging from 2 to 10 μg mL-1 [12]. We have also 
pointed out that this class of diterpenes may be potentially employed in the further development of 
new natural anti-caries agents [12]. In view of these significant results against oral bacteria as well as 
the need of novel compounds that can be employed as endodontic irrigants, we have decided to 
investigate the effect of these natural products on a panel of representative microorganisms responsible 
for root canal infections. 
 
2. Results and Discussion  
 
The chemical structures of the diterpenes evaluated in the present work are shown in Figure 1. The 
spectral data of all compounds are in agreement with those previously reported in the literature: 1, 2, 5, 
and 6 [13,14], 3 [15], 4 [16], 7 and 8 [12]. The 1H- and 13C-NMR spectral data indicate that the purity 
of each evaluated compound grade fell between 95-98%. 
In the present work we describe the effective antimicrobial activity displayed by some pimarane-
type diterpenes isolated from the dichloromethane extract of the roots of V. arenaria (DREVa) as well 
as two semi-synthetic derivatives 7 and 8 against important endodontic anaerobes by means of MIC 
and MBC values. Analysis of our results (Table 1) show that the compounds ent-pimara-8(14),15-
dien-19-oic acid (PA, 2), ent-8(14),15-pimaradien-3β-ol (3) and the sodium salt 8 of PA, were the 
most active metabolites, showing very promising MIC values for most of the evaluated pathogens. 





























1:  R1= CH3; R2= H; R3= H
2:  R1= COOH; R2= H; R3= H
3:  R1= CH3; R2= OH; R3= H
4:  R1= CH2OH; R2= OH; R3= H
7:  R1= CH3; R2= OCOCH3; R3= H
8:  R1= COO-Na+; R2= H; R3= H




Table 1. In vitro antibacterial activity (MIC) of the pimarane-type diterpenes against 
endodontic pathogens. 
Microorganism (ATCC) Minimum Inhibitory Concentration (μg mL
-1) 
1 2 3 4 5 6 7 8 Chlor 
P. gingivalis (33277) * 1.25 10.0 40.0    1.0 0.92 
P. gingivalis (clinical isolate) * 2.0 10.0 * * * 60.0 1.25 1.85 
P. nigrescens (33563) * 2.0 10.0 50.0 60.0 60.0 40.0 1.5 0.92 
P. intermedia (clinical isolate) * 1.0 7.5 50.0 40.0 60.0 20.0 1.75 0.92 
F. nucleatum (25586) * * * * * * * * 1.85 
P. buccae (clinical isolate) * 4.0 4.0 4.0 1.5 2.25 1.75 2.25 0.92 
B. fragilis (25285) * 2.0 2.5 40.0 40.0 18.0 16.0 10.0 7.38 
A. naeslundii (19039) * 1.25 5.0 12.0 60.0 60.0 40.0 5.0 1.85 
A. naeslundii (clinical isolate) * * * * * * * * 1.85 
A. viscosus (clinical isolate) * * * * * * * * 3.69 
P. micros (clinical isolate) * 0.5 6.0 16.0    8.0 1.85 
E. faecalis (4082) * * * * * * * * 3.69 
E. faecalis (clinical isolate) * * * * * * * * 7.38 
A. actinomycetemcomitans 
(43717) * 4.0 10.0 * 40.0 40.0 * 1.25 7.38 
* Inactive in the evaluated concentrations (MIC values higher than 80.0 μg mL-1); Chlorhexidine 
(Chlor)- positive control. 
 
It is noteworthy that these metabolites inhibited [17,18] the growth of several important ATCC and 
clinical isolated bacteria involved in endodontic pathologies very efficiently. However, analysis of the 
results achieved for F. nucleatum (ATCC 25586), A. naeslundii (clinical isolate), A. viscosus (clinical 
isolate), E. faecalis (ATCC 4082 and isolated) reveals that these strains are not susceptible to any of 
the evaluated metabolites. Table 2 shows the MBC values of compounds 2, 3, and 8 for the strains 
whose MIC values were equal to or lower than 10.0 µg mL-1. The MBC values for these diterpenes 
were equal to or 2-8 times higher than its MIC values. 




Table 2. Minimum bactericidal concentration for the compounds 2, 3 and 8 against 
endodontic pathogens. 
Microorganisms (ATCC) Minimum Bactericidal Concentration (μg mL
-1) 
2 3 8 Chlor 
P. gingivalis (33277) 10.0 10.0 8.0 0.92 
P. gingivalis (clinical isolate) 10.0 40.0 8.0 1.85 
P. nigrescens (33563) 2.0 40.0 1.75 0.92 
P. intermedia (clinical isolate) 1.0 40.0 2.0 0.92 
P. buccae (clinical isolate) 4.0 14.0 5.0 0.92 
B. fragilis (25285) 2.0 2.5 14.0 7.38 
A. naeslundii (19039) 10.0 5.0 5.0 1.85 
P. micros (clinical isolate) 1.0 6.0 12.0 1.85 
A. actinomycetemcomitans (43717) 4.0 60.0 1.75 7.38 
Chlorhexidine (Chlor) - positive control; DMSO 5% water solution (negative control) did not affect 
the growth of the microorganisms. 
 
According to Ríos and Recio [17] and Gibbons [18], some considerations must be borne in mind in 
the study of antimicrobial assays of plant extracts, essential oils, and compounds isolated from natural 
sources. These authors have emphasized that MIC values higher than 100.0 μg mL-1 for pure 
metabolites are evidence of poor activity. On the other hand, isolated compounds that inhibit the 
growth of the microorganisms at concentrations below 10.0 μg mL-1 are considered very promising in 
the search for new anti-infection agents. On the basis of these criteria and analyzing ours results (Table 
1), the natural pimarane-type diterpenes 2 and 3, as well as the semi-synthetic compound 8 can be 
classified as potential candidates for the discovery of new antibacterial agents against endodontic 
pathogens. These results, in addition to the works previously reported in the literature about the 
antimicrobial activity of pimarane diterpenes [12,19,20] reinforce the great importance of this class of 
natural products in the search for new effective antimicrobial agents for application in dentistry. 
Several studies have demonstrated the significant antimicrobial activity displayed by diterpenes 
[12,19,21-25]. The mechanism(s) behind a possible antimicrobial effect of this class of natural 
products have not yet been elucidated. Recently, Urzúa et al. [26] and Wilkens et al. [27] suggested 
that these metabolites promote bacterial lysis due to their insertion into the lipophilic cell membrane 
and its consequent disruption. According to these authors, the structural features that promote the 
efficient antibacterial effect displayed by these natural compounds include a lipophilic decalin ring 
system, capable of insertion into a lipophilic region, and one strategically positioned hydrogen-bond-
donor group (HBD; hydrophilic group), capable of interactions with the membrane phosphorylated 
groups. Moreover, in this study it was emphasized that a second HBD introduced in the decalin ring 
system led to reduction in or suppression of the activity. A careful observation of the results (Table 1) 
reveals that compounds 2, 3, and 8, which contain only one HBD at C-3 or C-19, display MIC values 
much lower than that observed for diterpene 1, which has no HBD. Also, it is noteworthy that the 
presence of two HBDs in the ent-pimaranes skeletons (compounds 4, 5 and 6) drastically reduces the 
antimicrobial activity displayed for most pathogens evaluated in the present study. Based on these 
considerations, our results give support to the mechanism of action suggested by Urzúa et al. [26] and 
Wilkens et al. [27].  
Urzúa et al. [26] have also demonstrated that the efficiency of hydrogen-bond-interactions between 
the phosphorylated groups in the membrane and the HBD in the diterpene are very important for the 




antibacterial activity. In this work it is demonstrated that kaurenoic acid (KA; Figure 2) is much more 
active than its respective methyl ester (KA-Me; Figure 2). The docking of these compounds into a 
model using phosphatidylcholine bilayer revealed that KA-Me is more deeply embedded into the 
hydrophobic region of the membrane compared with KA, presumably diminishing the capacity of the 
molecule to disrupt or damage the cell membrane. This observation is also in agreement with our 
results when the MIC values displayed by the ent-pimarane diterpenes 3 and 7 are compared (Table 1). 
For these compounds, the fact that the hydroxyl at C-3 is substituted with an acetyl group considerably 
diminishes its antimicrobial activities. 
 




KA-Me: R= CH3  
 
Also in agreement with this idea, it is remarkable that the sodium salt of PA (compound 8), 
obtained by saponification of PA, exhibits improved antimicrobial activity against the tested 
endodontic bacteria, compared with its parent form. In fact, our research group has already observed 
this pattern of activity when considering PA, its sodium salt, and a panel of Gram positive bacteria 
[12,19]. Moreover, this rule can also be applied to the antimicrobial activity displayed by another 
diterpene acid (ent-kaurenoic acid, KA, Figure 2) against oral pathogens (unpublished results). These 
results suggest that obtaining salts from acidic diterpenes is a successful strategy for increasing its 
antimicrobial activity. 
According to several authors [7,8,28], drugs derived from medicinal plants can serve not only as 
new drugs themselves but also as prototypes suitable for optimization through several approaches, 
including medicinal and semi-synthetic strategies. In summary, pimarane-type diterpenes are an important 
class of natural products and should be considered in the search for new dental root canal irrigants. 




NMR spectra were recorded on a Bruker DPX 400 spectrometer (400 MHz for 1H and 100 MHz for 
13C). Samples were dissolved in CDCl3 or CD3OD, with TMS as internal reference; chemical shifts are 
given in ppm. 
3.2. Plant material  
Viguiera arenaria Baker (Asteraceae) was collected by F.B. Da Costa from the vicinity of the 
Washington Luís highway (km 223, 22°10 S, 47°59 W, SP, Brazil, in March 1999), and was identified 
by J. N. Nakajima (Universidade Federal de Uberlândia, MG, Brazil) and E. E. Schilling (University 




of Tennessee, TN, USA). A voucher specimen was deposited in the herbarium of the Departamento de 
Biologia; Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto; Universidade de São Paulo; SP; 
Brazil (SPFR 4006). 
3.3. Extraction and isolation 
An aliquot (8.0 g) of the dichloromethane crude extract from the roots of V. arenaria (VaDRE) was 
suspended in a CH3OH/H2O solution (9:1 v/v) and partitioned with n-hexane and dichloromethane 
(DCM) (5 x 300 mL). The n-hexane (2.0 g) and DCM fractions (1.0 g) were fractioned using several 
chromatographic techniques, such as vacuum liquid chromatography, flash chromatography, and 
preparative thin-layer chromatography, as well as recrystallization with methanol, as previously 
described [29]. These procedures furnished the following compounds: ent-8(14),15-pimaradiene (1; 
100.0 mg); ent-pimara-8(14),15-dien-19-oic acid (PA; 2; 200.0 mg); ent-8(14),15-pimaradien-3β-ol (3; 
100.0 mg); ent-8(14),15-pimaradiene-3β,19-diol (4; 20.0 mg); ent-15-pimarene-8β,19-diol (5; 5.0 mg); 
7β-hydroxy-ent-pimara-8(14),15-dien-19-oic acid (6; 10.0 mg). 
 
3.4. Semi-synthetic derivatives  
Compound 7 (37.0 mg) was obtained from 3 (50.0 mg) as described by Da Costa et al. [30]. 
Compound 8 (40.0 mg) was prepared from 2 (50.0 mg) according to Daló et al. [31]. The chemical 
structures of these compounds were established by 1H- and 13C-NMR spectral data analysis and 
comparison with literature data [12]. 
 
3.5. Determination of the minimal inhibitory concentration and minimal bactericidal concentration 
 
The minimal inhibitory concentration values (MIC) and the minimal bactericidal concentration 
(MBC) of the pure diterpenes were determined in triplicate by using the microdilution broth method in 
96-well microplates [32,33]. The tested strains were obtained from the American Type Culture 
Collection (ATCC) and clinical isolate. The following microorganisms were used in the present work: 
Porphyromonas gingivalis (ATCC 33277), Porphyromonas gingivalis (clinical isolate), Prevotella 
nigrescens (ATCC 33563), Prevotella intermedia (clinical isolate), Prevotella buccae (clinical isolate), 
Fusobacterium nucleatum (ATCC 25586), Bacteroides fragilis (ATCC 25285), Actinomyces 
naeslundii (ATCC 19039), Actinomyces naeslundii (clinical isolate), Actinomyces viscosus (clinical 
isolate), Peptostreptococcus micros (clinical isolate), Enterococcus faecalis (ATCC 4082), 
Enterococcus faecalis (clinical isolate), and Aggregatibacter actinomycetemcomitans (ATCC 43717). 
The samples were dissolved in dimethyl sulfoxide (DMSO) at 1.0 mg mL-1, followed by dilution in 
schadler broth (DIFCO, Kansas City, MO, USA) supplemented with hemin (5.0 µg mL-1) and vitamin 
K1 (10 µg mL-1) for anaerobic bacteria; E. faecalis and A. actinomycetemcomitans were diluted in 
tryptic soy broth (DIFCO) as a facultative microorganism and microaerophili, respectively; 
concentrations ranging from 80.0 to 0.25 μg mL-1 were achieved. The final DMSO content was 5% 
(v/v), and this solution was used as negative control. The inoculum was adjusted for each organism, to 
yield a cell concentration of 5 × 105 colony forming units (CFU) mL-1, according to previously 




standardization by the Clinical Laboratory Standards Institute [32,33]. One inoculated well was 
included, to allow control of the adequacy of the broth for organism growth. One non-inoculated well, 
free of antimicrobial agent, was also included, to ensure medium sterility. Chlorhexidine 
dihydrochloride was used as positive control. The microplates (96-wells) were sealed with plastic film. 
The time necessary for growth was 24 hours for E. faecalis and A. actinomycetemcomitans, and 96 
hours for anaerobes, incubated at 37 °C under appropriate gaseous conditions [facultative in aerobiose; 
microaerophili in an atmosphere of 10% CO2; anaerobe in an anaerobic work station (Don Whitley 
Scientific, Bradford, UK), in an atmosphere of 5–10% H2, 10% CO2, 80–85% N2]. After that, resazurin 
(30 μL) in aqueous solution (0.02%) was added to the microplates, to indicate microorganism viability 
[34]. Before the addition of resazurin and in order to determine MBC, an aliquot of the inoculum was 
aseptically removed from each well presenting no apparent growth, and then plated onto agar Schadler 
(DIFCO) supplemented with hemin (5.0 µg mL-1), vitamin K1 (10.0 µg mL-1), and sheep blood (5%) 
for anaerobic bacteria. E. faecalis and A. actinomycetemcomitans were plated in tryptic soy agar 
(DIFCO) supplemented with 5% sheep blood; the plates were incubated as previously described. 
Determination of the MBC values was only performed for the most active compounds (2, 3 and 8), 
against the strains whose MIC values were very promising (equal to or lower than 10.0 µg mL-1) 
[17,18]. 
 
4. Conclusions  
 
According to several authors [7,8,28], drugs derived from medicinal plants can serve not only as 
new drugs themselves, but also as prototypes suitable for optimization through several approaches, 
including medicinal and semi-synthetic strategies. According to our rersults pimarane-type diterpenes 
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